![Mark A. Smith](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark A. Smith
Chief Tech/Sci/R&D Officer at BRIGHT MINDS BIOSCIENCES INC.
Net worth: - $ as of 31/05/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Ian McDonald | M | 37 | 5 years | |
Maggie FitzPatrick | F | 58 | 3 years | |
Ann Cunningham | F | 56 | 5 years | |
Mark Flather | M | - | 3 years | |
Nils Bottler | M | 37 | 4 years | |
Jessica Haskell | F | - | 2 years | |
Jan Pedersen | M | 59 | 2 years | |
Ross Baker | M | - | 3 years | |
Mary Rotunno | F | 64 | 3 years | |
Mark McPartland | M | 58 | 8 years | |
Jeremy Fryzuk | M | 39 | 4 years | |
Joanne Curley | M | 56 | 3 years | |
Josie Afolabi | F | - | 14 years | |
Trisha Fitzmaurice | F | - | 2 years | |
Erik Berglund | M | - | 3 years | |
Gideon Shapiro | M | 64 | 4 years | |
Louis Monti | M | - | 4 years | |
Iskra Reic | F | - | 23 years | |
Adrian Charles Noel Kemp | M | 58 | 15 years | |
David Weiner | M | 59 | 1 years | |
Margareta Elisabeth Björk | M | 62 | 22 years | |
Susan Mary Galbraith | M | - | 14 years | |
Ryan Cheung | M | 45 | 4 years | |
Mark Ginski | M | - | 3 years | |
Thomas Lategan | M | 65 | 3 years | |
Reid Adler | M | 70 | 2 years | |
Joshua Prince | M | 54 | 3 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
H. Ralph Snodgrass | M | 74 | 24 years | |
Simon Lowth | M | 61 | 6 years | |
David Brennan | M | 70 | 13 years | |
Leif Valdemar Johansson | M | 73 | 11 years | |
Jeff Jonas | M | 71 |
Shire Plc /Old/
![]() Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 5 years |
Geneviéve B. Berger | M | 69 | 9 years | |
Briggs Morrison | M | 65 | 3 years | |
Donald Bruce Burlington | M | 75 | 7 years | |
Jean-Philippe Courtois | M | 63 | 8 years | |
Gavin Hill | M | 56 | 8 years | |
David Smith | M | - | 9 years | |
Shriti Vadera | F | 62 | 7 years | |
Menelas Pangalos | M | 57 | 13 years | |
James Ward-Lilley | M | 59 | 1 years | |
Jacques Dumas | M | 58 | 7 years | |
Michael Zinda | M | 53 | 16 years | |
Douglas Williamson | M | 61 | 1 years | |
Nancy Rothwell | M | 68 | 9 years | |
Håkan Söderberg | M | - | 5 years | |
Brian Underdown | M | 83 | 12 years | |
Michele Hooper | F | 72 | 9 years | |
Louis Schweitzer | M | 80 | 8 years | |
Peter Bonfield | M | 80 | 12 years | |
Graham Chipchase | M | 61 | 9 years | |
John Varley | M | 67 | 9 years | |
Rudolph Markham | M | 78 | 11 years | |
Frank Yocca | M | 68 | 10 years | |
Antoine Yver | M | 66 | 7 years | |
James M. Mackay | M | - | 8 years | |
Elaine Sullivan | M | 63 | 15 years | |
Rahul Kakkar | M | 49 | 4 years | |
Magnus Sjoegren | M | - | 2 years | |
Claire Brown | M | 53 | 8 years | |
Gianfranco Nazzi | M | - | 7 years | |
Graeme H. R. Musker | M | - | 16 years | |
Xu Dong Yin | M | 58 | 7 years | |
Chris Degnan | M | 44 | 10 years | |
Richard Bungay | M | 55 | 2 years | |
Martin Brenner | M | 54 | 1 years | |
Maria Koehler | M | 67 | 7 years | |
Sharon Benzeno | M | 50 | 6 years | |
John Gustofson | M | - | 4 years | |
Jim Kastenmayer | M | 52 | 7 years | |
Percy N. Barnevik | M | 83 | 5 years | |
Tao Deng | M | 68 | 6 years | |
Sarah Holland | F | 61 | 5 years | |
Ellis Wilson | M | - | 1 years | |
Glenn Wilson | M | - | 5 years | |
Carl Firth | M | 51 | 9 years | |
Hock Kee Wee | M | 63 | 7 years | |
James Ferguson | M | 70 | 6 years | |
Anthony Zook | M | 63 | 3 years | |
Martin MacKay | M | 68 | 3 years | |
Bahija Jallal | M | 62 | 11 years | |
Barrie John Thorpe | M | 76 | - | |
David Elkins | M | 55 | 2 years | |
Bruno Francois Jules Angelici | M | 77 | 21 years | |
Graham Dixon | M | 63 | 8 years | |
Bo Angelin | M | 73 | - | |
David Smith | M | 58 | 8 years | |
Reginald Seeto | M | 52 | 5 years | |
Glenn A. Miller | M | - | - | |
Revati Shreeniwas | M | 63 | 2 years | |
Sylvie Grégoire | M | 62 |
Shire Plc /Old/
![]() Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 6 years |
Esra Erkal-Paler | F | - | 7 years | |
Tim Watts | M | 66 | 22 years | |
Jane Ellen Henney | M | 76 | 10 years | |
Laurent Condomine | M | 79 | - | |
Jonathan Symonds | M | 66 | 10 years | |
Kazuhiro Kurihara | M | 56 | - | |
Curt Mikael von Euler-Chelpin | M | 71 | 10 years | |
Erna Möller | F | - | 8 years | |
John Patterson | M | 76 | - |
Statistics
Country | Connections | % of total |
---|---|---|
United Kingdom | 73 | 73.00% |
United States | 27 | 27.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Mark A. Smith
- Personal Network